Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Bausch Health Companies ( (TSE:BHC) ).
On May 9, 2025, John S. Barresi announced his resignation as the Senior Vice President, Controller, and Chief Accounting Officer of Bausch Health Companies Inc., effective June 2, 2025, to pursue another opportunity. His departure is not due to any disagreements with the company, and during his remaining time, he will aid in a smooth transition. The company is searching for a permanent replacement, and in the interim, Jean-Jacques Charhon, the Executive Vice President and Chief Financial Officer, will take on the additional role of Chief Accounting Officer.
The most recent analyst rating on (TSE:BHC) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Bausch Health Companies stock, see the TSE:BHC Stock Forecast page.
Spark’s Take on TSE:BHC Stock
According to Spark, TipRanks’ AI Analyst, TSE:BHC is a Neutral.
Bausch Health’s overall score reflects its solid revenue growth and cash flow generation capabilities, countered by high leverage and ongoing profitability issues. Technical indicators and valuation metrics are unfavorable, while recent earnings calls provide some optimism. Addressing financial stability and profitability concerns is crucial for long-term improvement.
To see Spark’s full report on TSE:BHC stock, click here.
More about Bausch Health Companies
Average Trading Volume: 395,967
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$2.41B
See more insights into BHC stock on TipRanks’ Stock Analysis page.